Anti-CD19 CAR T as a feasible therapy for refractory/relapsed mixed phenotype acute leukemia patients.

Authors	Xiangqun Li, Kylan Chen, Hailong Zhang, Xian Zhang, Junfang Yang, Jing Liu, Jianwei Zheng, Fei Dong, Yongbo Zhu, Jiao Yu, Haihong Zhang, Peihua Lu, Bo Chen
Journal	Pediatric blood & cancer (Pediatr Blood Cancer) Vol. 69 Issue 10 Pg. e29657 (10 2022) ISSN: 1545-5017 [Electronic] United States
PMID	35373883 (Publication Type: Letter)
Chemical References	Antigens, CD19 Receptors, Chimeric Antigen
Topics	Antigens, CD19 Humans Immunotherapy, Adoptive Leukemia Phenotype Receptors, Chimeric Antigen Recurrence

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!